The Pharmaceutical Benefits Advisory Committee will consider a range of potential new listings at its March 2023 meeting, including a fixed-dose immunotherapy combination for melanoma and a new cholesterol-lowering biologic. …
PBAC to consider anticipated new therapies at its March meeting
November 24, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
If the demand is to pay for reform, are these reforms really worth paying for?
May 18, 2026 - - Latest News -
Government sidesteps committee call on CGMs, insulin pumps and GLP‑1 access
May 18, 2026 - - Latest News -
Budget papers signal the work that has already been done on reform proposals
May 18, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 15 May
May 15, 2026 - - Podcast -
New Zealand still falling behind on access to modern medicines
May 15, 2026 - - Latest News -
AusBiotech welcomes Budget's creation of new National Resilience and Science Council
May 15, 2026 - - Latest News -
Minister fired the starting gun in March, he flung the door open in Budget week
May 14, 2026 - - Latest News